ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : Molecular epidemiology
Scheme : Programs
Clear All
Filter by Field of Research
Optical technology (3)
Health Promotion (2)
Medical and Health Sciences (2)
Oncology and Carcinogenesis (2)
Pharmacology and Pharmaceutical Sciences (2)
Allergy (1)
Cell Development (Incl. Cell Division And Apoptosis) (1)
Clinical Pharmacology and Therapeutics (1)
Medical and Health Sciences not elsewhere classified (1)
Medical biochemistry - carbohydrates (1)
Medical parasitology (1)
Nutrigenomics and personalised nutrition (1)
Nutrition and dietetics not elsewhere classified (1)
Oncology And Carcinogenesis (1)
Ophthalmology and optometry not elsewhere classified (1)
Respiratory Diseases (1)
Solid Tumours (1)
Venereology (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (24)
Filter by Status
Closed (24)
Filter by Scheme
Programs (24)
Filter by Country
Australia (4)
Filter by Australian State/Territory
QLD (2)
VIC (2)
ACT (1)
NSW (1)
SA (1)
  • Researchers (0)
  • Funded Activities (24)
  • Organisations (30)
  • Funded Activity

    Towards Cancer Control: Population And Molecular Strategies

    Funder
    National Health and Medical Research Council
    Funding Amount
    $5,468,491.00
    More information
    Funded Activity

    Gynaecological, Oesophageal And Skin Cancer In Australia: Developing The Evidence-base

    Funder
    National Health and Medical Research Council
    Funding Amount
    $6,079,935.00
    Summary
    Our Program addresses cancers of the ovary, uterus, oesophagus and skin (both melanoma and non-melanoma skin cancers). The first three cancers together affect almost 4,000 people and cause more than 2,000 deaths every year while skin cancer affects almost 400,000 Australians each year. Our aims are, first, to understand better how these cancers are caused so that we can try to prevent them in the future; second, to enhance diagnosis of these cancers; and third, to improve the survival and qualit .... Our Program addresses cancers of the ovary, uterus, oesophagus and skin (both melanoma and non-melanoma skin cancers). The first three cancers together affect almost 4,000 people and cause more than 2,000 deaths every year while skin cancer affects almost 400,000 Australians each year. Our aims are, first, to understand better how these cancers are caused so that we can try to prevent them in the future; second, to enhance diagnosis of these cancers; and third, to improve the survival and quality of life for people who are diagnosed with these cancers in Australia.
    Read more Read less
    More information
    Funded Activity

    Beyond BRCA1 And BRCA2: Pathways To Breast Cancer

    Funder
    National Health and Medical Research Council
    Funding Amount
    $5,126,456.00
    Summary
    Breast Cancer is a very common disease in women and although huge progress has been made in the last two decades, much remains to be done to improve our understanding of different types of breast cancer and its management. This program brings together the expertise of three senior researchers: 2scientists and 1 medical scientist. Dr Trench has an interest in identifying genes involved in cancers arising in patients who have a strong family history. She will use molecular methods and cohorts of p .... Breast Cancer is a very common disease in women and although huge progress has been made in the last two decades, much remains to be done to improve our understanding of different types of breast cancer and its management. This program brings together the expertise of three senior researchers: 2scientists and 1 medical scientist. Dr Trench has an interest in identifying genes involved in cancers arising in patients who have a strong family history. She will use molecular methods and cohorts of patients enrolled with Kathleen Cunningham Foundation for Research into Familial Breast and Ovarian Cancer to identify the genes responsible, assess their distribution in the population and determine whether these genes also play a role in non-familial cancers. Dr Khanna's work examines the complex array of enzymes that are responsible for maintaining the integrity of the DNA, and investigates how failure of these mechanisms leads to damage of the genetic material which ultimately results in cancer. It is known that genes involved in familial predisposition code for proteins that work as DNA repair enzymes. It is also known that different types of breast cancer exist, each with differing behaviour and response to treatment and that they are associated with specific genetic changes, including those associated with a familial predisposition. Prof Lakhani's interest lies in using microscopy and the latest molecular tools to refine the classification of these different types of breast tumour so that they can be managed appropriately by his surgical and oncological colleagues. A better understanding of the genetic changes and underlying biology of different types of breast cancer will lead to individualised and specific therapy for patients. This program brings together a unique combination, nationally and internationally, that investigates cancers at the level of genes and cells and translates the information to the clinic for the benefit of patient management.
    Read more Read less
    More information
    Funded Activity

    Epidemiological Studies In Maternal And Child Health

    Funder
    National Health and Medical Research Council
    Funding Amount
    $5,917,440.00
    More information
    Funded Activity

    Beyond BRCA1 And BACA2

    Funder
    National Health and Medical Research Council
    Funding Amount
    $3,474,222.00
    Summary
    To understand the genetic basis of two of the most important cancers in women, breast and ovarian cancer. The team has already identified one gene that confers a very high risk of breast cancer and may account for a large proportion of 'familial' breast cancer. Their aim is to identify additional predisposition genes and to determine their normal function in the cell, as well as the way in which they contribute to the development of cancer
    More information
    Funded Activity

    Epidemiology Of Chronic Disease, Health Interventions And DNA Studies

    Funder
    National Health and Medical Research Council
    Funding Amount
    $8,107,547.00
    More information
    Funded Activity

    Clinical Trials Advances For Better Health Outcomes

    Funder
    National Health and Medical Research Council
    Funding Amount
    $8,012,612.00
    Summary
    The NHMRC Clinical Trials Centre (CTC) aims to use clinical trials and methodological research in trials to improve health in Australia and internationally. Its research program will initiate major new clinical trials and a comprehensive program of research into trial methods, biostatistical analysis, health outcome analysis and decision analysis. Patient preferences and decision making, particularly in cancer, will be a focus. CTC uses data from its own and other clinical trials in combined ana .... The NHMRC Clinical Trials Centre (CTC) aims to use clinical trials and methodological research in trials to improve health in Australia and internationally. Its research program will initiate major new clinical trials and a comprehensive program of research into trial methods, biostatistical analysis, health outcome analysis and decision analysis. Patient preferences and decision making, particularly in cancer, will be a focus. CTC uses data from its own and other clinical trials in combined analyses to arrive at better evidence. The NHMRC program grant will allow important research studies to be integrated with trials funded from industry and other sources and will maintain the CTC’s internationally competitive research team at the cutting edge of new trial methods and systems.
    Read more Read less
    More information
    Funded Activity

    Early Developmental Pathways Linking Health, Disability, Education, Welfare And Justice

    Funder
    National Health and Medical Research Council
    Funding Amount
    $10,440,204.00
    Summary
    This research will use information from birth, death and medical records for all births in WA from 1980 linked to records of disability, education, justice and welfare, to map, for the first time in Australia, the pathways to good and poor outcomes over a child’s lifetime. This will bring a new focus on to how early development affects health and participation in society and will identify new ways to improve the lives of all children, regardless of their social circumstances.
    More information
    Funded Activity

    New Evidence To Guide Decisions About The Prevention And Treatment Of Common Cardiovascular Diseases.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $7,309,675.00
    Summary
    The Program brings together clinicians, epidemiologists and statisticians in a unique endeavour designed to improve the prevention and treatment of heart attack and stroke. For the foreseeable future, these conditions will remain leading causes of death and disease in Australia and most other countries in the region. While there are many established treatment and prevention strategies for these conditions there remains great potential for further advances to be made, which might avert very large .... The Program brings together clinicians, epidemiologists and statisticians in a unique endeavour designed to improve the prevention and treatment of heart attack and stroke. For the foreseeable future, these conditions will remain leading causes of death and disease in Australia and most other countries in the region. While there are many established treatment and prevention strategies for these conditions there remains great potential for further advances to be made, which might avert very large numbers of premature deaths and serious disabling outcomes. This Program of research seeks to provide new information that will give patients, doctors and policy makers innovative options for the treatment and prevention of heart attack and stroke. The Program will incorporate two main elements: observational studies and randomised controlled trials. The observational studies will establish the precise importance of each of the main causes of cardiovascular diseases (such as diabetes, blood pressure, smoking and cholesterol) at different ages, in different ethnic groups and in different geographic regions. Furthermore, these studies will also define the relative importance of established and novel risk factors for cardiovascular disease, providing important new information about how resources for prevention should be directed. The large-scale trials will provide evidence about the effectiveness and safety of a range of new cardiovascular disease prevention and treatment strategies. The work will build on the team�s very successful approach of evaluating the effects of established interventions in high-risk groups for whom those particular treatments are not currently indicated.The Program will also include studies that address the critical issue of translating health research findings into practice _ in terms of health policy, clinical practice and consumer behaviour. A particular focus involves the application and evaluation of novel Internet technologies for promoting best practice. The methodologies used by the team will ensure that the evidence generated by the Program is as precise and reliable as possible, in order to provide a sound base to guide decisions about changes in health care policy and practice. The research findings will have direct relevance to the healthcare needs of millions of Australians within the next five years, and the impact of the work will be assured by the development of implementation and dissemination plans for each major component of the Program.
    Read more Read less
    More information
    Funded Activity

    Sitting Less And Moving More: Population Health Research To Understand And Influence Sedentary Behaviour

    Funder
    National Health and Medical Research Council
    Funding Amount
    $6,367,518.00
    Summary
    The majority of Australian adults spend most of their waking hours sitting: at home, at work, and in their cars; most do not participate in exercise or sport. This leads to weight gain and to diseases of inactivity (particularly diabetes, heart disease, cancer and depression). New research will measure sitting time and the physical activity in people's daily lives, what factors encourage inactivity, and how to increase activity levels, especially among the ageing 'baby boomer' population.
    More information

    Showing 1-10 of 24 Funded Activites

    • 1
    • 2
    • 3
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback